Asset Details
Do you wish to reserve the book?
Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma
Do you wish to request the book?
Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma
2005
Overview
Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating folate metabolism, which affects DNA methylation and synthesis. Two functional, common polymorphisms (C677T and A1298C) are known in the MTHFR gene. MTHFR activity is lowered in individuals with the 677TT genotype and is somewhat reduced in those with the 1298CC genotype. We reviewed the consistency of reported associations of these polymorphisms with colorectal cancer and adenoma with consideration of the effects of nutritional status. A total of 16 studies have addressed the association between MTHFR C677T polymorphism and colorectal cancer in 10 countries. Decreased risk of colorectal cancer associated with the 677TT genotype has fairly consistently been observed, with few exceptions. This decrease was observable in people with either high or low folate status. Alteration in the thymidylate pool associated with MTHFR activity is postulated as an underlying mechanism. Studies on the A1298C polymorphism are limited, and their results are variable. Almost all of seven studies of colorectal adenoma have found no association between C677T polymorphism and adenoma, but the 677TT genotype seems to be related to increased risk when folate status is poor. Reduced availability of methyl groups for DNA methylation might be more relevant to adenoma formation. Although the underlying mechanisms still remain to be clarified, epidemiological findings regarding MTHFR C677T polymorphism provide strong evidence that adequate folate status confers protection from colorectal cancer. (Cancer Sci 2005; 96: 535 –542)
Publisher
Blackwell Science Pty,Blackwell
Subject
/ Biological and medical sciences
/ Colorectal Neoplasms - genetics
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Genetic Predisposition to Disease
/ Genotype
/ Humans
/ Methylenetetrahydrofolate Reductase (NADPH2) - genetics
/ Review
/ Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
/ Tumors
